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ABSTRACT Carbapenemase genes in Enterobacteriaceae are mostly described as be-
ing plasmid associated. However, the genetic context of carbapenemase genes is
not always conﬁrmed in epidemiological surveys, and the frequency of their chro-
mosomal integration therefore is unknown. A previously sequenced collection of
blaKPC-positive Enterobacteriaceae from a single U.S. institution (2007 to 2012; n 
281 isolates from 182 patients) was analyzed to identify chromosomal insertions of
Tn4401, the transposon most frequently harboring blaKPC. Using a combination of
short- and long-read sequencing, we conﬁrmed ﬁve independent chromosomal inte-
gration events from 6/182 (3%) patients, corresponding to 15/281 (5%) isolates.
Three patients had isolates identiﬁed by perirectal screening, and three had infec-
tions which were all successfully treated. When a single copy of blaKPC was in the
chromosome, one or both of the phenotypic carbapenemase tests were negative. All
chromosomally integrated blaKPC genes were from Klebsiella spp., predominantly K.
pneumoniae clonal group 258 (CG258), even though these represented only a small
proportion of the isolates. Integration occurred via IS15-ΔI-mediated transposition of
a larger, composite region encompassing Tn4401 at one locus of chromosomal inte-
gration, seen in the same strain (K. pneumoniae ST340) in two patients. In summary,
we identiﬁed ﬁve independent chromosomal integrations of blaKPC in a large out-
break, demonstrating that this is not a rare event. blaKPC was more frequently inte-
grated into the chromosome of epidemic CG258 K. pneumoniae lineages (ST11,
ST258, and ST340) and was more difﬁcult to detect by routine phenotypic methods
in this context. The presence of chromosomally integrated blaKPC within successful,
globally disseminated K. pneumoniae strains therefore is likely underestimated.
KEYWORDS carbapenemase, KPC, Klebsiella, Klebsiella pneumoniae carbapenemase,
antibiotic resistance, chromosomal, plasmid analysis, plasmids, transposons, whole-
genome sequencing
Carbapenem resistance in Enterobacteriaceae has become a major clinical challenge(1). Within this bacterial family, carbapenemase genes are largely located on
plasmids cocirculating with various strains (2). Plasmid DNA may act as a temporary
“lending library,” enabling genes of importance to survive various selective pressures
(3). However, in vitro and modeling data suggest that once a gene is incorporated
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chromosomally, it will be maintained through replication without selective pressure,
and gene loss from the bacterial population becomes less likely (4–6).
The Klebsiella pneumoniae carbapenemase gene (blaKPC) is maintained within the
self-mobilizing 10-kb transposon Tn4401 (7). The frequency of transposition in vitro is
relatively high (4.4  106/recipient cell) and without site speciﬁcity, but the rate of
movement outside laboratory settings is largely unknown (8). Nevertheless, Tn4401 has
been described in several different genetic environments (9, 10).
Historically, most descriptions of blaKPC have been in a globally successful lineage of
K. pneumoniae, namely, multilocus sequence type 258 (ST258) and the associated clonal
group 258 (CG258), which includes ST11, ST258, and ST340 (11). CG258 isolates are
widespread, albeit concentrated in geographic hotspots, with the blaKPC gene being
plasmid associated in the majority of reports (9). Interestingly, the earliest observed
chromosomal Tn4401 integration events have been sporadic and in non-Klebsiella spp.:
Pseudomonas aeruginosa in 2006 (12), Raoultella spp. in 2008 (13) and Acinetobacter
baumannii in 2009 (14). More recently, chromosomal integration among K. pneumoniae
ST258 (n 4) isolates has been described in the United States by three separate groups
(15–17).
The rate of chromosomal integration within clinical settings for many genetic
elements is largely unknown. Chromosomal integration of blaKPC may be under-
reported, as its investigation often requires detailed genetic analysis, and if a plasmid
copy is present then a chromosomal copy may be overlooked. Even high-resolution
genetic methods, such as whole-genome sequencing (WGS) using short-read technol-
ogies, can be confounded by the presence of multiple copies of Tn4401 and/or
repetitive ﬂanking sequences, which limit the ability to accurately reconstruct the
genetic context(s) of blaKPC (10, 18). Here, we use a combination of short- and long-read
WGS to investigate chromosomal integration of blaKPC among 281 isolates (62 distinct
strains) of blaKPC-positive Enterobacteriaceae isolated from 182 patients in a single
hospital.
RESULTS
Identiﬁcation of chromosomal integrations of blaKPC. There were 62 distinct
strains (from 13 species) among 281 sequenced K. pneumoniae carbapenemase (KPC)-
Enterobacteriaceae isolates derived from 182 infected/colonized patients (18). Using de
novo assemblies to identify isolates where Tn4401 was adjacent to known chromosomal
sequences, 44% (123/281) of isolates, from 82/182 (45%) patients, were evaluable
(Table 1). In 7/123 evaluable isolates, from 3/82 patients, Tn4401 ﬂanking sequence
showed homology with chromosomal reference sequences, indicating a likely chromo-
somal location for blaKPC. Three different chromosomal loci were identiﬁed, one for
each patient, demonstrating three distinct Tn4401 chromosomal integration events.
Isolates from two of the patients were K. pneumoniae (ST258 and ST340, with earliest
isolates CAV1453 and CAV1417, respectively), and one was K. oxytoca (CAV1752).
As the de novo assembly approach was only able to assess 44% of isolates for
possible chromosomal integrations, we also used a mapping approach, which is
unaffected by multiple Tn4401 copies. Reassuringly, all seven isolates identiﬁed by the
de novo assembly approach described above were also identiﬁed by this method as
having a likely chromosomal integration of Tn4401. In addition, the mapping approach
identiﬁed a further 11 isolates as having putative chromosomal integrations, all of
which were unevaluable by the de novo assembly approach. Six of these were K.
pneumoniae ST11 isolates from a single patient (the earliest isolate was CAV1351). Three
were K. pneumoniae ST340 isolates from two additional patients (earliest isolates were
CAV1217 and CAV1518). One was a non-CG258 K. pneumoniae isolate (ST244; CAV1042)
from an additional patient, and one was a K. oxytoca isolate (CAV1755) unrelated to
CAV1752 (40,000 single-nucleotide variant [SNV] differences), also from an additional
patient.
To conﬁrm the chromosomal locations of Tn4401, we used long-read sequencing.
For 6/8 patients identiﬁed above, the earliest isolate from each was sequenced using
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PacBio. In 5/6 cases, the presence of Tn4401 on the chromosome was conﬁrmed, and
in one case (CAV1042) it was refuted. For one of the two remaining patients (the earliest
isolate was CAV1351), we did not perform additional PacBio sequencing, as a subse-
quent isolate from the same patient (CAV1392; 1 SNV difference from CAV1351) was
previously PacBio sequenced as part of another study and shown to contain two copies
of Tn4401, one chromosomal and one plasmid (18). CAV1518 from the ﬁnal patient was
not PacBio sequenced, as it was demonstrated using other methods (see below) to be
a false positive from the mapping approach, since Tn4401 was not present on the
chromosome.
Altogether, we found ﬁve distinct loci of chromosomal integration of blaKPC veriﬁed
by long-read sequencing from six patients, with two additional patients having isolates
that were falsely identiﬁed by the mapping approach (Table 2). All chromosomal
integrations were in Klebsiella spp., mostly K. pneumoniae CG258, even though CG258
represented only a small proportion of the outbreak (4/18 versus 2/164 non-CG258
patients, P  0.0009; 13/34 versus 2/247 isolates, P  0.0001; Fisher’s exact test).
Mechanism of chromosomal integration in K. pneumoniae ST340. There were
three patients with K. pneumoniae ST340 isolates where the mapping approach iden-
tiﬁed Tn4401 as having a possible chromosomal location (CAV1417, CAV1217, and
CAV1518) (Table 2). To assess the molecular basis of chromosomal integration, the
chromosomal region encompassing Tn4401 in the closed PacBio assembly of the ST340
CAV1417 isolate was aligned to the NJST258_2 reference (GenBank accession number
CP006918), which belongs to the closely related ST258. Relative to the reference,
CAV1417 had a 24-kb inversion and a 16-kb insertion, which included Tn4401 and
several other resistance genes (Fig. 1A).
At one end of the 16-kb region was an IS15-ΔI element, highly genetically similar (3
nucleotide differences) to IS26, both of which undergo replicative transposition with
8-bp target site duplication (TSD) (19). IS26 has been shown to undergo frequent
intramolecular transposition, which can result in inversion of the sequence between the
original and duplicated elements. This process disrupts the pairing of TSD sequences,
which can be used to trace the history of transposition events (20).
The other end of the 16-kb region terminated in a sequence with high similarity to
the 14-bp IS15-ΔI inverted repeat (IR) sequence (IS15-ΔI, GGCACTGTTGCAAA; other,
GGCTTTGTTGAATA; 10/14 nucleotide identities), suggesting that this acted as a cryptic
recognition site mediating transposition of the entire 16-kb region, similar to a com-
TABLE 1 Species breakdown for isolates that were evaluable by the de novo assembly
approach and chromosomal references used for mapping
Species
No. (%) of evaluable
isolates for de novo
assembly approach
Reference strain for
mapping approach
Reference
accession no.
Citrobacter amalonaticus 0/2 (0) CAV1321a (Citrobacter
freundii)
CP011612
Citrobacter freundii 17/30 (57) CAV1321 CP011612
Enterobacter aerogenes 3/4 (75) EA1509E NC_020181.1
Enterobacter asburiae 1/1 (100) NCTC 9394b
(Enterobacter cloacae)
NC_021046.1
Enterobacter cloacae 18/96 (19) NCTC 9394 NC_021046.1
Escherichia coli 2/2 (100) DH10B NC_010473.1
Klebsiella pneumoniae 42/94 (45) MGH78578 CP000647.1
Klebsiella oxytoca 33/35 (94) E718 NC_018106.1
Kluyvera intermedia 3/7 (43) CAV1151 CP011602
Proteus mirabilis 0/1 (0) HI4320 NC_010554.1
Raoultella ornithinolytica 0/1 (0) B6 NC_021066.1
Serratia marcescens 4/5 (80) WW4 NC_020211.1
Other (unknown) 0/3 (0) NCTC 9394a (E. cloacae) NC_021046.1
Total 123/281 (44)
aNo species-speciﬁc reference available.
bE. cloacae reference used for simplicity, as E. asburiae is part of the E. cloacae complex.
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posite transposon. The 8-bp ﬂanking sequences of the 16-kb region were identical to
the 8-bp ﬂanking sequences of a neighboring IS15-ΔI element located at the other end
of the 24-kb inversion relative to NJST258_2 (Fig. 1A). This indicates that the 16-kb
region initially integrated into the chromosome by intermolecular transposition, with
an 8-bp TSD (GTGATGGC). Subsequently, IS15-ΔI underwent intramolecular transposi-
tion, resulting in a 24-kb inversion, with duplication of a second 8-bp sequence
(TTCAGATG), with one copy ﬂanking each of the duplicated elements.
In CAV1217, long-read sequencing demonstrated two copies of Tn4401, one chro-
mosomal and one plasmid. For the chromosomal copy, the 8-bp sequence adjacent to
the non-IS15-ΔI side of the 16-kb region (Fig. 1, right side) was identical to CAV1417
(GTGATGGC), while the plasmid copy had a different 8-bp ﬂanking sequence (CGTAG-
GCA).
In CAV1518, the above-described signature of chromosomal integration (GTGATGGC
sequence adjacent to the 16-kb region) is not present (Fig. 1B). Instead, the ﬂanking
sequence is identical to the plasmid copy in CAV1217 (CGTAGGCA). Therefore, the
16-kb region is most likely plasmid located in CAV1518, indicating that this isolate was
a false positive from the mapping method.
Clinical microbiologic characteristics. Susceptibility results and phenotypic test-
ing for these isolates varied substantially (Table 2). K. pneumoniae CAV1453, CAV1351,
A
NJST258_2
CAV1417
TTCAGATG* GTGATGGC* TTCAGATG GTGATGGCATGAA
ATGAA
Tn4401
16 kb region
Other
IS15-deltaI
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0
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150 GTGATGGC
ATGAA ATGAAB
CAV1417
Co
ve
ra
ge
0
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100
150 CGTAGGCA
GTGATGGC
ATGAA ATGAA
CAV1217
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ge
Position (bp)
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TACTC
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FIG 1 Chromosomal integration of Tn4401 in Klebsiella pneumoniae ST340 isolates. (A) Alignment of 50-kb region of the CAV1417 chromosome with the
homologous region of the NJST258_2 reference genome. Pink and blue shading indicate high sequence similarity (99.8%) in the same or opposite
orientations, respectively. Flanking sequences for mobile elements present in the complete (PacBio) CAV1417 genome are indicated (an asterisk indicates that
the sequence shown has been reverse complemented). (B) Coverage of Illumina reads for CAV1417, CAV1217, or CAV1518 mapped to the complete CAV1417
genome across the region shown in panel A. Flanking sequences for Tn4401 and the right side of the 16-kb region were determined from the mapped Illumina
reads.
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and CAV1417 were high-level carbapenem resistant but with weak to negative carbap-
enemase phenotypes. All of these isolates had a sequence disruption in major K.
pneumoniae porin channels (ompK35 and/or ompK36) (Table 2). CAV1453 had only a
single Tn4401 copy in the chromosome; however, it was Tn4401a, which generally
results in increased KPC expression compared to Tn4401b, as was seen here with a
higher level of expression compared to the other isolates with a single copy of Tn4401b
in the chromosome (21, 22). It was negative by indirect carbapenemase testing (23) but
weakly positive by the modiﬁed Hodge test. CAV1417 had a single chromosomal copy
of Tn4401b, and phenotypic testing for carbapenemase activity was consistently neg-
ative, with low-level blaKPC expression by quantitative PCR. Despite negative carbap-
enemase production by phenotypic tests, CAV1417 was highly carbapenem resistant
and had disruptions in both ompK35 and ompK36. The functional consequences of
these disruptions have not been conﬁrmed, but loss of function of these genes is
expected to increase carbapenem resistance above that conferred by KPC alone (11, 21,
22, 24).
K. oxytoca isolate CAV1755 was carbapenem resistant and phenotypically positive by
carbapenemase testing. This was also true for the K. pneumoniae isolate CAV1042,
which was ultimately rejected as having a chromosomal copy. Both of these isolates
had multiple loci of Tn4401 integration (including a plasmid) with increased coverage
of Tn4401b relative to the chromosome and also demonstrated increased blaKPC
expression and intact porin channel sequences.
CAV1217 was not noted to be blaKPC positive until the patient was found to be
colonized through perirectal screening (25) with a K. pneumoniae isolate with a weakly
positive indirect carbapenemase test. This prompted further testing of the phenotyp-
ically carbapenem-susceptible K. pneumoniae urine isolate (CAV1217), which was then
found to be blaKPC PCR positive. This isolate had no disruption in the ompK35 and
ompK36 coding regions and had two copies of Tn4401 (one plasmid and one chromo-
somal) but with relatively low coverage.
K. oxytoca CAV1752, which had a single chromosomal copy of Tn4401b with
low-level expression by quantitative PCR (qPCR), was detected on perirectal screening,
again with conﬂicting phenotypic results (Table 2) (23). On automated susceptibility
testing (VITEK 2), it was predicted to be susceptible to ceftriaxone and cefepime (MIC
of 1 g/ml) and carbapenems, with an aztreonam MIC of 4 g/ml. Analysis of porin
genes demonstrated an insertion disrupting ompK35.
Clinical course and epidemiology. All six patients conﬁrmed to have chromosomal
integration of blaKPC had multiple risk factors and prolonged hospital exposure either
within our health system or at outside hospitals prior to transfer (Table 3). Several
patients with extensive outside health care exposure had isolates identiﬁed relatively
early during hospitalization, raising the possibility of isolates circulating elsewhere in
the region at outside hospitals. Interestingly, the patient with CAV1518 (the ST430 K.
pneumoniae without chromosomal integration but with an ancestor common to
CAV1217 and CAV1417) presented at an outside hospital prior to exposure to our
health system, consistent with persistence of this lineage elsewhere in the region.
There were three patients who had infections (two with ventilator-associated pneu-
monia and one complicated urinary tract infection) with a K. pneumoniae isolate with
chromosomal integration of blaKPC. The outcomes were complete microbiologic reso-
lution and clinical cure at 30 days without any patients having known relapse within
our health system.
The two patients with distinct strains of K. oxytoca (CAV1752 and CAV1755) did not
demonstrate signs of infection with these isolates, thus the clinical consequences
remain unclear. Interestingly, both patients had been colonized months before with
other blaKPC-positive Enterobacteriaceae. As new acquisition at our institution is rela-
tively rare and there were no other patients with similar isolates, this ﬁnding suggests
separate within-patient horizontal transfer and chromosomal integration of Tn4401.
Mathers et al. Antimicrobial Agents and Chemotherapy
March 2017 Volume 61 Issue 3 e01823-16 aac.asm.org 6
 o
n
 M
ay 3, 2017 by UC London Library Services
http://aac.asm
.org/
D
ow
nloaded from
 
TA
B
LE
3
C
lin
ic
al
an
d
ep
id
em
io
lo
gi
ca
l
ch
ar
ac
te
ris
tic
s
Is
ol
at
e
So
ur
ce
an
d
d
at
e
(m
o/
yr
)
of
ea
rl
ie
st
is
ol
at
e
w
it
h
ch
ro
m
os
om
al
in
te
g
ra
ti
on
Ep
id
em
io
lo
g
y
(lo
ca
l
an
d
ou
ts
id
e-
h
os
p
it
al
ex
p
os
ur
e)
C
om
or
b
id
it
y(
ie
s)
Tr
ea
tm
en
t
ch
ar
ac
te
ri
st
ic
In
fe
ct
io
n
w
it
h
K
PC
is
ol
at
e
w
it
h
ch
ro
m
os
om
al
in
te
g
ra
ti
on
a
Tr
ea
tm
en
t
30
-d
ay
ou
tc
om
e
Pr
io
r
b
ro
ad
-s
p
ec
tr
um
in
tr
av
en
ou
s
an
ti
m
ic
ro
b
ia
l
in
la
st
90
d
ay
s
V
en
ti
la
to
r
fo
r
>
48
h
(d
ur
in
g
th
at
h
os
p
it
al
st
ay
)
In
d
w
el
lin
g
ce
n
tr
al
ve
n
ou
s
ca
th
et
er
Fo
le
y
ca
th
et
er
In
IC
U
fo
r
>
48
h
C
A
V1
35
1
Sp
ut
um
,2
/2
01
1
H
os
p
ita
l
da
y
5;
ex
te
ns
iv
e
ou
ts
id
e-
ho
sp
ita
l
ex
p
os
ur
e
Pe
rs
is
te
nt
re
sp
ira
to
ry
fa
ilu
re
in
se
tt
in
g
of
in
ﬂu
en
za
p
ne
um
on
ia





Ye
s,
VA
P
M
er
op
en
em
,t
ig
ec
yc
lin
e,
am
ik
ac
in
M
ic
ro
b
io
lo
gi
c
an
d
cl
in
ic
al
cu
re
C
A
V1
45
3
Pe
rir
ec
ta
l,
10
/2
01
1
H
os
p
ita
l
da
y
3;
ex
te
ns
iv
e
ou
ts
id
e-
ho
sp
ita
l
ex
p
os
ur
e
C
er
eb
ra
l
p
al
sy
,c
hr
on
ic
ve
nt
ila
to
r
de
p
en
de
nc
e





N
o
N
A
b
N
A
C
A
V1
21
7
U
rin
e,
8/
20
10
H
os
p
ita
l
da
y
3
(h
ad
si
m
ila
r
K.
pn
eu
m
on
ia
e
in
ur
in
e
on
ad
m
is
si
on
w
hi
ch
w
as
no
t
re
ta
in
ed
);
ex
te
ns
iv
e
ou
ts
id
e-
ho
sp
ita
l
ex
p
os
ur
e
D
ia
b
et
es
m
el
lit
us
,
re
cu
rr
en
t
U
TI
s





Ye
s,
cU
TI
Fo
le
y
ca
th
et
er
ex
ch
an
ge
w
ith
m
er
op
en
em
fo
r
72
h
ch
an
ge
d
to
tig
ec
yc
lin
e
fo
r
la
ck
of
im
p
ro
ve
m
en
t
(p
er
si
st
en
t
sy
m
p
to
m
s
an
d
un
ch
an
ge
d
b
ac
te
ria
l
b
ur
de
n)
M
ic
ro
b
io
lo
gi
c
an
d
cl
in
ic
al
cu
re
C
A
V1
41
7
U
rin
e,
5/
20
11
H
os
p
ita
l
da
y
36
C
hr
on
ic
ve
nt
ila
to
r,
ne
ur
om
us
cu
la
r
w
ea
kn
es
s





Ye
s,
VA
P
M
er
op
en
em
an
d
co
lis
tin
M
ic
ro
b
io
lo
gi
c
an
d
cl
in
ic
al
cu
re
C
A
V1
75
2
Pe
rir
ec
ta
l,
12
/2
01
2
H
os
p
ita
l
da
y
10
0;
ﬁr
st
bl
a K
P
C
-p
os
iti
ve
is
ol
at
e
w
as
K.
pn
eu
m
on
ia
e
id
en
tiﬁ
ed
3
m
o
ea
rli
er
du
rin
g
p
rio
r
ho
sp
ita
liz
at
io
n
O
rt
ho
to
p
ic
liv
er
tr
an
sp
la
nt





N
o
N
A
N
A
C
A
V1
75
5
A
b
do
m
in
al
dr
ai
na
ge
,
12
/2
01
2
H
os
p
ita
l
da
y
26
;ﬁ
rs
t
bl
a K
P
C
-p
os
iti
ve
is
ol
at
e
w
as
E.
ae
ro
ge
ne
s,
id
en
tiﬁ
ed
10
m
o
ea
rli
er
du
rin
g
p
rio
r
ho
sp
ita
liz
at
io
n
En
d-
st
ag
e
re
na
l
di
se
as
e,
di
ab
et
es
m
el
lit
us
,
co
m
p
lic
at
ed
in
tr
a-
ab
do
m
in
al
in
fe
ct
io
n





N
o
N
A
(h
ad
b
ee
n
p
re
vi
ou
sl
y
su
cc
es
sf
ul
ly
tr
ea
te
d
fo
r
E.
ae
ro
ge
ne
s
in
tr
a-
ab
do
m
in
al
in
fe
ct
io
n
N
A
a
cU
TI
,c
om
p
lic
at
ed
ur
in
ar
y
tr
ac
t
in
fe
ct
io
n;
VA
P,
ve
nt
ila
to
r-
as
so
ci
at
ed
p
ne
um
on
ia
.
b
N
A
,n
ot
ap
p
lic
ab
le
.
Chromosomal Integration of blaKPC Antimicrobial Agents and Chemotherapy
March 2017 Volume 61 Issue 3 e01823-16 aac.asm.org 7
 o
n
 M
ay 3, 2017 by UC London Library Services
http://aac.asm
.org/
D
ow
nloaded from
 
DISCUSSION
We demonstrate, for the ﬁrst time, multiple instances of chromosomal integration of
Tn4401/blaKPC within a single-center outbreak. Although this is not the ﬁrst description
of chromosomal integration of Tn4401, the frequency of integration in a clinical setting
is largely unknown and likely overlooked. With a focused effort on identifying all
instances of chromosomal integration, this event does not appear to be rare. In
addition, we found that phenotypic carbapenemase testing was variable in these
contexts, and blaKPC could be missed by nonmolecular methods.
Illumina sequencing is increasingly used to undertake epidemiological investigation
but is limited in investigating multicopy regions, which are of particular relevance to
assessing resistance genes and mobile genetic elements. We utilized two bioinformatic
approaches to characterize the genetic contexts of Tn4401. First, we used a de novo
assembly approach, which identiﬁed three distinct chromosomal integrations. These
were all veriﬁed by PacBio sequencing, demonstrating the robustness of this method.
However, the method cannot identify chromosomal integration if multiple copies of
Tn4401 are present or if Tn4401 is ﬂanked by repetitive sequences, and only 44% of
isolates were evaluable using this method. Second, we used a mapping approach
which was able to assess all isolates but which identiﬁed several false positives.
Therefore, results from the mapping approach on its own should be interpreted with
caution, and a combination of methods may be most appropriate for other studies
investigating sequence-based identiﬁcation of resistance gene integration into the
chromosome.
blaKPC chromosomal integration was overrepresented among CG258 strains in our
outbreak, suggesting that it is more widespread in high-risk clones such as K. pneu-
moniae ST258. This phenomenon has been seen in the high-risk Escherichia coli ST-131
clone, with chromosomal integration of the CTX-M beta-lactamase gene followed by
vertical transmission (26, 27). It remains unclear if there is a propensity for chromosomal
integration among certain K. pneumoniae strains or, more likely, whether integration is
associated with the extended timespan over which these strains have been associated
with Tn4401, representing greater opportunity for random integration.
Within K. pneumoniae ST340, we identiﬁed three patients with putative chromo-
somal integrations of Tn4401, conﬁrmed by PacBio sequencing in two isolates, CAV1217
and CAV1417. Comparison of the chromosomal region surrounding Tn4401 in CAV1417
to a related strain lacking Tn4401, combined with the analysis of TSD sequences,
allowed us to reconstruct the history of transposition events. This revealed that
chromosomal integration of Tn4401 occurred via IS15-ΔI-mediated transposition of a
16-kb region encompassing Tn4401. Further analysis of TSD sequences from Illumina
data for CAV1518 revealed that the 16-kb region was not integrated into the chromo-
some in this isolate but rather shared ﬂanking sequence with the plasmid copy from
CAV1217. Taken together, this indicates that Tn4401 most likely was acquired once in
this lineage, in a common ancestor of all three isolates, with chromosomal integration
occurring after the divergence of CAV1518 (in the ancestor of CAV1217 and CAV1417)
and subsequent loss of the plasmid copy in CAV1417 (Fig. 2).
Another important feature of this study was the variability in phenotypic carbap-
enem resistance. A prior evaluation of phenotypic carbapenemase testing in Entero-
bacteriaceae from our institution (May 2010 to December 2011), using an ertapenem
MIC of 1 g/ml by VITEK 2 for inclusion, demonstrated that the indirect carbapen-
emase test had 90% sensitivity for detecting blaKPC-producing isolates (23). Isolates
with chromosomally integrated blaKPC accounted for 3 of the 5 false-negative blaKPC
Enterobacteriaceae identiﬁed in that study (total of 56 isolates tested). -Lactamase
carriage on high-copy-number plasmids compared to low-copy-number plasmids is
known to alter the degree of resistance seen phenotypically (22, 28). Here, we found
preliminary evidence that a single chromosomal copy of Tn4401 was associated with a
more subtle carbapenemase phenotype and lower expression of blaKPC. For example,
CAV1752 would not have been detected with our current methods. This also could
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contribute to the misclassiﬁcation of these isolates in a typical clinical microbiology
laboratory, where the cost of molecular screening is often prohibitive (25).The differ-
ential impact on expression of resistance of blaKPC located in the chromosome alone
remains an interesting ﬁnding but will require additional in vitro studies to conﬁrm this
effect.
The impact of porin channel alterations may also affect the degree of in vitro
resistance, highlighted here when comparing the related isolates CAV1417 and
CAV1217. Although CAV1217 had two Tn4401 copies and CAV1417 a single copy,
CAV1417 had disruptions in both porin channel genes and was more phenotypically
resistant. Nevertheless, porin channel loss does not always result in high resistance (e.g.,
CAV1752 has a disruption in ompK35 but remained carbapenem susceptible), and the
prediction of phenotype from genotype in these cases is challenging.
Our small number of cases is insufﬁcient to reliably assess the clinical impact of low
MICs and subtle phenotypes associated with chromosomal integration. However, these
cases are not notably distinct from other descriptions of infection with blaKPC-positive
K. pneumoniae, with all infected patients ultimately responding to therapy (29). Inter-
estingly, CAV1217 was phenotypically susceptible; however, despite 48 h of mero-
penem treatment with an initial Foley exchange, the patient had persistent symptoms
and no change in bacterial burden but was ultimately treated successfully with
tigecycline (Table 3).
This work also highlights that the frequency of chromosomal integration of genes of
drug resistance is largely unknown and would be missed by most methods. Even with
WGS, sophisticated focused analysis was required to identify chromosomal integration
when a plasmid copy was also present. Currently, blaKPC is carried within a replicative
transposon, and although the in vitro transposition frequency of this element is
relatively high, the real-world rate is unknown (8). Although the frequency of chromo-
somal integration cannot be fully assessed without additional study, this remains an
intriguing preliminary ﬁnding from prospectively collected isolates in a clinical setting.
In summary, we present ﬁve independent examples of chromosomal integration of
Tn4401-blaKPC in Klebsiella spp. from six patients among a comprehensively character-
ized outbreak, indicating that chromosomal integration is not an infrequent event. We
FIG 2 Schematic showing the presumed sequence of events affecting blaKPC in Klebsiella pneumoniae ST340
isolates.
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also demonstrate that chromosomal integration often may be overlooked even with
WGS, especially when multiple Tn4401 copies are present. In the clinical microbiology
laboratory, phenotypic tests for carbapenem resistance/carbapenemase production
were variable and could also miss these cases. Thus, chromosomal integration of blaKPC
was relatively common, was difﬁcult to detect, and may facilitate stable inheritance of
blaKPC, representing an evolutionary adaptation with potential implications for surveil-
lance and treatment.
MATERIALS AND METHODS
Isolate collection, characterization, and selection for whole-genome sequencing. We previously
described short-read (Illumina) sequencing of 281 blaKPC-positive Enterobacteriaceae isolates, from 182
patients, collected between August 2007 and December 2012 in the University of Virginia Health System
(18). These isolates comprised 62 distinct strains, deﬁned on the basis of phylogenetic clustering, using
cutoffs of 500 single-nucleotide variants (SNVs). Long-read (PacBio) sequencing was carried out on a
random subset of 17 isolates (18). For the work presented here, an additional six isolates underwent
long-read sequencing with PacBio technology as previously described (30).
Sequence analysis. We used three methods to identify chromosomally integrated Tn4401/blaKPC.
First, we used a de novo assembly approach. Illumina reads from each isolate were assembled using
Velvet and VelvetOptimiser (31). We then queried these with BLASTn, using 400 bp of sequence from
each end of Tn4401 in order to identify contigs containing possible Tn4401 junction sequences. Isolates
were evaluable if 400 bp of Tn4401 sequence plus 400 bp of ﬂanking sequence were present on a
single contig for at least one of the two Tn4401 ends. For evaluable isolates, Tn4401 ﬂanking sequences
were ﬁrst compared to known plasmid ﬂanking sequences from previously performed long-read se-
quencing of a subset of the 281 isolates (18). For isolates that did not show a match to any of these
plasmid references, Tn4401 ﬂanking sequences were used as BLASTn queries against NCBI’s nucleotide
database, with homology to chromosomal sequences taken as evidence for a likely chromosomal
location.
Second, we used a mapping approach. For each of the 281 isolates, Illumina reads were mapped to
a reference consisting of a species-speciﬁc chromosome (Table 1) plus the pKPC_UVA01 Tn4401b-1
sequence (18). For ﬁve isolates, there was no species-speciﬁc reference available, and we used a closely
related species instead (Table 1). Mapping was performed using bwa mem version 0.7.12-r1039 (32) with
default parameters, and the output was ﬁltered to remove supplementary alignments. For read pairs
where one read mapped within 1 kb of either end of the Tn4401 sequence and the other read mapped
to the chromosome, the corresponding position of mapping in the chromosome was extracted from the
bam ﬁle. The length of the chromosome was divided into 1-kb nonoverlapping windows, and 10 reads
within a single window were taken as evidence for chromosomal integration of Tn4401.
Third, we used long-read PacBio sequencing (18, 30), fully resolving the genetic ﬂanking structures
around Tn4401, in order to validate the ﬁndings of putative chromosomal integration from the short-read
analyses described above. In all cases where multiple isolates were identiﬁed from the same patient
using the short-read approaches described above, these represented the same strain and chromosomal
locus. Therefore, we performed long-read sequencing on the earliest isolate identiﬁed from each of the
eight patients, with two exceptions (i.e., six isolates in total). We did not perform long-read sequencing
on CAV1351, as a later isolate from the same patient (CAV1392) was previously PacBio sequenced as part
of another study (18), or on CAV1518, as this isolate was demonstrated not to have a chromosomal
integration of blaKPC by further analysis of Illumina data (see Results).
For Tn4401 relative coverage estimation, we mapped reads to a two-contig reference (Tn4401 contig
plus chromosome contig) as described above for the mapping approach. The average coverage of
Tn4401 relative to the chromosome was calculated as (number of reads mapping to Tn4401/length of
Tn4401 contig)  (length of chromosome contig/number of reads mapping to chromosome).
For determination of 5-bp sequences ﬂanking Tn4401 in ST340 isolates, reads were mapped to the
Tn4401b-1 reference (18) using bwa mem as described above. For each read mapped to the start/end of
Tn4401b-1 with 5 bp ﬂanking the start/end position, the 5-bp region immediately adjacent to the
start/end position was extracted. Five-base-pair sequences with 10 counts were excluded to account
for sequencing errors. Determination of 8-bp sequences ﬂanking the 16-kb composite region was
performed similarly, except that the CAV1417 genome was used as a reference, with reads mapping to
30 bp of the end of the 16-kb region within this extracted, and 8-bp ﬂanking sequences were
determined. Because the IS15-ΔI sequence exists as multiple copies in the ST340 isolates, it is not possible
to determine ﬂanking sequences using Illumina data for this end of the 16-kb region (Fig. 1, left side).
Therefore, this analysis was only performed for the other (non-IS15-ΔI) end (Fig. 1, right side).
Analysis of porin genes was performed using tBLASTn comparisons against the de novo assembly of
each patient’s earliest isolate, with translated ompK35 and ompK36 K. pneumoniae reference sequences
(AJ011501 and JX291114, respectively) as queries. Reading frame disruptions were reported as likely
loss-of-function mutations.
Expression of blaKPC. Total RNA was extracted using the RNeasy minikit (Qiagen, GmBH, Hilden,
Germany) and underwent column DNase I digestion (Qiagen) as recommended by the manufacturer.
cDNA was synthesized from RNA in accordance with the manufacturer’s instructions (qScript cDNA
supermix; Quanta Biosciences, Gaithersburg, MD). Twenty nanograms of RNA equivalent DNA was used
in triplicate. Quantitative reverse transcription-PCR (qRT-PCR) was performed using SsoFast EvaGreen
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supermix (Bio-Rad Laboratories, Hercules, CA), template DNA, and 500 nM each primer RT-KPC-F/RT-
KPC-R, K. oxytoca rpoB-F/rpob-R, or K. pneumoniae rpoB-F/rpoB-R. Relative quantiﬁcation of gene
expression was determined using the averaged cycle threshold (CT) values for each isolate using the Pfafﬂ
method (33). This equation uses an expression ratio to normalize the expression levels of blaKPC to the
transcriptional level of the constitutively expressed rpoB gene.
Clinical microbiology. Enterobacteriaceae cultured from clinical (August 2007 to December 2012)
and surveillance (starting in April 2009) specimens prospectively underwent carbapenemase phenotypic
testing using the modiﬁed Hodge test (August 2007 to June 2008) or the indirect carbapenemase test
(July 2008 to December 2012). These tests were repeated for all isolates from frozen subculture (23). The
earliest available isolate with chromosomal integration from each patient underwent multiple modes of
phenotypic testing, including the VITEK 2 system using a GN70 card (bioMérieux, Durham, NC), disc
diffusion, Etest (bioMérieux, Durham, NC), and broth microdilution of meropenem to determine suscep-
tibilities by following the CLSI’s and manufacturers’ guidelines (34).
Clinical characteristics. Electronic medical records were reviewed for treatment, clinical outcome,
location and timing of transfer, and exposure to other patients with blaKPC-producing Enterobacteriaceae
(approved by IRB 13558).
Accession number(s). Sequence data have been deposited in GenBank as follows: CAV1042,
CP018671.1; CAV1392, CP011578.1; CAV1453, CP018356.1; CAV1217, CP018676.1; CAV1417, CP018352.1;
CAV1752, CP018362.1; CAV1755, MRWY00000000.
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